scispace - formally typeset
Z

Zhi Xu

Researcher at Wuhan University of Science and Technology

Publications -  37
Citations -  1623

Zhi Xu is an academic researcher from Wuhan University of Science and Technology. The author has contributed to research in topics: Isatin & Antimycobacterial. The author has an hindex of 17, co-authored 35 publications receiving 1258 citations.

Papers
More filters
Journal ArticleDOI

Quinoline hybrids and their antiplasmodial and antimalarial activities.

TL;DR: This review aims to summarize the recent advances towards the discovery of antiplasmodial and antimalarial hybrids including quinoline skeleton to provide an insight for rational designs of more active and less toxic quinolines hybrids antimalarials.
Journal ArticleDOI

Isatin hybrids and their anti-tuberculosis activity

TL;DR: This review outlines the advances in the application of isatin hybrids as antimycobacterial agents and the critical aspects of design and structure–activity relationship of these derivatives.
Journal ArticleDOI

Recent developments of coumarin-containing derivatives and their anti-tubercular activity

TL;DR: This review outlines the advances in the application of coumarin-containing derivatives as anti-TB agents and the critical aspects of design and structure-activity relationship of these derivatives.
Journal ArticleDOI

Recent advances of tetrazole derivatives as potential anti-tubercular and anti-malarial agents.

TL;DR: This review covers the recent advances of tetrazole derivatives as potential anti-tubercular and anti-malarial agents, and the structure-activity relationship is also discussed for the further rational design of tetazole derivatives.
Journal ArticleDOI

Azide-alkyne cycloaddition towards 1H-1,2,3-triazole-tethered gatifloxacin and isatin conjugates: Design, synthesis and in vitro anti-mycobacterial evaluation.

TL;DR: Twelve novel 1H-1,2,3-triazole-tethered gatifloxacin (GTFX) isatin conjugates 5a-l with greater lipophilicity compared with GTFX were designed, synthesized and evaluated for in vitro anti-mycobacterial activities against M. tuberculosis (MTB) H37Rv and MDR-TB as well as cytotoxicity.